Paroxetine for social anxiety and alcohol use in dual‐diagnosed patients

  title={Paroxetine for social anxiety and alcohol use in dual‐diagnosed patients},
  author={C. Randall and Michael R. Johnson and Angelica K. Thevos and Susan C. Sonne and Suzanne E. Thomas and Shauna L. Willard and Kathleen T. Brady and M. D. Jonathan R. Davidson},
  journal={Depression and Anxiety},
  • C. Randall, Michael R. Johnson, +5 authors Jonathan R. Davidson, M.D.
  • Published 2001
  • Psychology, Medicine
  • Depression and Anxiety
  • The objective of this study was to compare the efficacy and tolerability of paroxetine to matched placebo in adults with co‐occurring social anxiety disorder and alcohol use disorder. Outcome measures included standardized indices of social anxiety and alcohol use. Fifteen individuals meeting DSM‐IV criteria for both social anxiety disorder and alcohol use disorder were randomized to treatment. Paroxetine (n = 6) or placebo (n = 9) was given in a double‐blind format for 8 weeks using a flexible… CONTINUE READING
    96 Citations

    Topics from this paper

    Paroxetine reduces social anxiety in individuals with a co-occurring alcohol use disorder.
    • 50
    Treating individuals with social anxiety disorder and at-risk drinking: phasing in a brief alcohol intervention following paroxetine.
    • 6
    • PDF
    Levetiracetam for the Treatment of Co-Occurring Alcohol Dependence and Anxiety: Case Series and Review
    • J. Mariani, F. Levin
    • Psychology, Medicine
    • The American journal of drug and alcohol abuse
    • 2008
    • 14
    Treatment of Comorbid Alcohol Dependence and Anxiety Disorder: Review of the Scientific Evidence and Recommendations for Treatment
    • 20
    • PDF
    Pharmacotherapy for social anxiety disorder: a systematic review
    • 55
    Pharmacotherapy for anxiety and comorbid alcohol use disorders.
    • 39
    Pharmacotherapy for Alcohol‐Related Disorders: What Clinicians Should Know
    • 21


    Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study.
    • 340
    Treatment of social phobia with gabapentin: a placebo-controlled study.
    • 368
    Nefazodone in social phobia.
    • 63
    Functional impairment in social phobia.
    • 491
    Placebo-controlled trial of moclobemide in social phobia.
    • 128